Bank Pictet & Cie (Europe)’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,784
Closed -$365K 167
2022
Q3
$365K Hold
6,784
0.02% 130
2022
Q2
$274K Sell
6,784
-1,661
-20% -$82.3K 0.01% 138
2022
Q1
$559K Buy
8,445
+1,625
+24% +$111K 0.02% 118
2021
Q4
$682K Sell
6,820
-1,147
-14% -$119K 0.02% 120
2021
Q3
$996K Buy
7,967
+339
+4% +$40.3K 0.04% 107
2021
Q2
$947K Buy
7,628
+1,941
+34% +$261K 0.03% 106
2021
Q1
$868K Buy
+5,687
New +$859K 0.03% 106

Other funds holding GH

Bank Pictet & Cie (Europe)'s GH Position: Q4 2022 in Review

Bank Pictet & Cie (Europe) sold out of Guardant Health (GH) in Q4 2022, closing a stake of 6,784 shares — an estimated $365K sold.

Bank Pictet & Cie (Europe) first reported a position in GH in Q1 2021 and held it in 7 quarters. The position peaked at $996K in Q3 2021. 292 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Bank Pictet & Cie (Europe) reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 6,784 Guardant Health shares in Q4 2022, an estimated $365K.
  • Bank Pictet & Cie (Europe) first reported a position in Guardant Health in Q1 2021 and held it in 7 quarters.
  • Bank Pictet & Cie (Europe)'s Guardant Health position peaked at $996K in Q3 2021.
  • 292 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q4 2022, filed 8 Feb 2023.